GlassScriptPhysician profile
Mee Hoe Han
NPI 1710212568
$3,605.77
in general payments reported to CMS, 2019-2025
26 companies · $515 in 2025
The $515 reported for 2025 was more than what 87% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,694 · 2022: $488 · 2023: $499 · 2024: $409 · 2025: $515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,422.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,156.52 | 2021 | |
| Abbvie INC. | $457.85 | 2021-2023 | |
| Astellas Pharma US INC | $327.19 | 2023-2025 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $285.81 | 2021-2025 | Injectafer |
| Mayne Pharma Commercial LLC | $244.95 | 2022-2025 | |
| Hologic Sales and Service, LLC | $182.06 | 2023-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Evofem Biosciences, INC. | $147.33 | 2022 | |
| Therapeuticsmd, INC. | $146.71 | 2021-2022 | |
| Agile Therapeutics, INC. | $113.65 | 2021-2022 | |
| Exeltis, USA INC. | $75.92 | 2021-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $64.06 | 2021-2025 | |
| Pharmacosmos Therapeutics INC. | $61.83 | 2023 | Monoferric |
| Organon LLC | $56.71 | 2021-2024 | Nexplanon |
| Coopersurgical, INC. | $33.83 | 2021-2025 | Paragard T 380a |
| Exact Sciences Corporation | $31.99 | 2025 | Cologuard Collection Kit |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $29.23 | 2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $28.85 | 2023-2025 | Gardasil 9 |
| Pfizer INC. | $26.07 | 2022-2023 | |
| Optumhealth Care Solutions, LLC | $19.92 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Mycovia Pharmaceuticals, INC. | $19.80 | 2023 | Vivjoa |
| Coloplast Corp | $19.61 | 2024 | |
| Millicent US INC | $18.30 | 2025 | Femlyv |
| Biohaven Pharmaceutical Holding Company LTD. | $15.66 | 2022 | |
| Myovant Sciences INC. | $15.32 | 2022 | |
| Supernus Pharmaceuticals, INC. | $14.11 | 2025 | Qelbree |
| Mylan Pharmaceuticals INC. | $12.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mee Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.